Study summary · research use only
Effects of pancragen on the differentiation of pancreatic cells during their ageing
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This study (species not specified) examined the effect of the tetrapeptide pancragen on differentiation of pancreatic cells during ageing, noting that expression of differentiation markers was reduced during ageing of pancreatic cells. Pancragen was reported to stimulate expression of differentiation factors of acinar cells (Pdx1, Ptfla) and islet of Langerhans cells (Pdx1, Pax6, Pax4, Foxa2, NKx2.2) in "young" and "aged" cultures. The authors suggest that differentiation of acinar and islet pancreatic cells induced by pancragen may be a mechanism underlying its anti-diabetic and anti-inflammatory effects, describing transcription factors regulating differentiation of pancreatic cells as a pharmacological target for pancragen in diabetes mellitus and pancreatitis.
Abstract
Expression of differentiation markers was found to be reduced during ageing of pancreatic cells. Tetrapeptide pancragen stimulates the expression of differentiation factors of acinar (Pdx1, Ptfla) and islet of Langerhans (Pdx1, Pax6, Pax4, Foxa2, NKx2.2) cells in "young" and " aged" cultures. Differentiation of acinar and islet pancreatic cells induced by pancragen can be a mechanism underlying its anti-diabetic and anti-inflammatory effects. Thus, transcription factors that regulate differentiation of pancreatic cells are a pharmacological target for pancragen, which allows considering it as an effective tool in the treatment of diabetes mellitus and pancreatitis.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.